Back to Journals » OncoTargets and Therapy » Volume 13
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
RETRACTED ARTICLE: Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs
Authors Sun F, Wu K , Yao Z, Mu X , Zheng Z, Sun M, Wang Y, Liu Z, Zhu Y
Received 15 December 2019
Accepted for publication 17 June 2020
Published 10 July 2020 Volume 2020:13 Pages 6755—6765
DOI https://doi.org/10.2147/OTT.S242441
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr William C. Cho
This paper has been retracted.
Sun F, Wu K, Yao Z, et al. Onco Targets Ther. 2020;13:6755–6765.
We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.
Since publication, concerns have been raised about the integrity of the data in the article. This includes the duplication of images from Figures 5 and 6. Specifically,
- The image for Figure 5C, NC, has overlap with the image for Figure 6D, NC.
When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As verifying the validity of the published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.